Hady Lichaa, MD, FACC, FSCAI, FSVM, RPVI (@hadylichaamd) 's Twitter Profile
Hady Lichaa, MD, FACC, FSCAI, FSVM, RPVI

@hadylichaamd

Assistant Professor @ Univ of TN Nashville. Interventional Cardiovasc specialist @ Ascension St Thomas Heart #CHIP #CLI #DVT. Tweets=My own only

ID: 915689246287126528

calendar_today04-10-2017 21:25:03

4,4K Tweet

5,5K Followers

1,1K Following

SCAI (@scai) 's Twitter Profile Photo

🩺 This #LimbLossAwarenessMonth, start the conversation with your patients. Encourage #PAD screening and proactive #vascular care. Early diagnosis and intervention are key to preventing limb amputations and severe complications. Get a #PulseOnPAD➡️ Padpulse.org

🩺 This #LimbLossAwarenessMonth, start the conversation with your patients. Encourage #PAD screening and proactive #vascular care. Early diagnosis and intervention are key to preventing limb amputations and severe complications.

Get a #PulseOnPAD➡️ Padpulse.org
Raj Tayal (@rajtayalmd) 's Twitter Profile Photo

Potential gamechanger in MCS! #Percutaneous insertion of the #Impella #5.5 device *may be feasible via a transaxillary approach #PercAx using the #Impella #RPFlex sheath in some patients. Use of a covered stent will likely be required for hemostasis.

Potential gamechanger in MCS! #Percutaneous insertion of the #Impella #5.5 device *may be feasible via a transaxillary approach #PercAx using the #Impella #RPFlex sheath in some patients. Use of a covered stent will likely be required for hemostasis.
Jay Mohan, D.O., FACC, FSCAI, FASE, RPVI (@drjaymohan) 's Twitter Profile Photo

EPD for Peripheral Atherectomy- routine use? Steps: ⚔️cross your lesion with wire of choice (I usually use 0.035/0.018 glide) 🚇Follow with your microcatheter (preferably 0.035) and pull your wire and deploy filter through the MC 🥅Most atherectomy requires 0.014 anyways,

Jon George (@jcgeorgemd) 's Twitter Profile Photo

Honored to be invited to participate as the #PeripheralTrackDirector at #SCAI2025 SCAI. Exciting educational programs covering complex peripheral arterial disease, venous disease, and carotid disease on the agenda! Binita Shah Sahil A. Parikh, MD Drew Klein

Honored to be invited to participate as the #PeripheralTrackDirector at #SCAI2025 <a href="/SCAI/">SCAI</a>.  Exciting educational programs covering complex peripheral arterial disease, venous disease, and carotid disease on the agenda!
<a href="/BinitaShahMD/">Binita Shah</a> <a href="/sahilparikhmd/">Sahil A. Parikh, MD</a> <a href="/DrDrewKleinPHI/">Drew Klein</a>
Jay Mohan, D.O., FACC, FSCAI, FASE, RPVI (@drjaymohan) 's Twitter Profile Photo

Diffuse ISR. How would you treat? hx of atretic LIMA ➕ 2 layers of stent in LAD. Recurrent diffuse ISR. Did laser 1.4 followed by brachytherapy which lasted him 3 years. Came back this week with this. Did cutting balloon and sending for repeat brachy. Thoughts? Multiple DCB?

Jay Mohan, D.O., FACC, FSCAI, FASE, RPVI (@drjaymohan) 's Twitter Profile Photo

CHRONIC #DVT toolbox Pt referred to me with continued sx and non resolving chronic DVT of the fem-pop segment. Occluded distal fem and pop. ☑️Crossed with Triforce and back end GA ⚜️Cleaned out with VenaCore Seems like finally we have some tools for chronic DVT #CardioX

Hady Lichaa, MD, FACC, FSCAI, FSVM, RPVI (@hadylichaamd) 's Twitter Profile Photo

#SCAIproud #SCAI has fought for our #ICrights all along With #SCAIPAC you’ll allow SCAI to advocate for you to have a happier professional experience and be rewarded for your hard work Best professional investment for #IC Andrew M. Goldsweig, MD, MS Allison Dupont, MD Yader Sandoval

#SCAIproud

#SCAI has fought for our #ICrights all along

With #SCAIPAC you’ll allow <a href="/SCAI/">SCAI</a> to advocate for you to have a happier professional experience and be rewarded for your hard work 

Best professional investment for #IC

<a href="/AGoldsweig/">Andrew M. Goldsweig, MD, MS</a> <a href="/Allison_Dupont/">Allison Dupont, MD</a> <a href="/yadersandoval/">Yader Sandoval</a>
Vladimir Lakhter (@vladlakhter) 's Twitter Profile Photo

Thread/ Very excited to see our RESCUE-II study in print JACC Journals Advances. In this study we evaluated bolus-only r-tPA w/o infusion for management of acute intermediate-risk PE. #CardioTwitter #ACCFIT sciencedirect.com/science/articl…

Thread/

Very excited to see our RESCUE-II study in print <a href="/JACCJournals/">JACC Journals</a> Advances.

In this study we evaluated bolus-only r-tPA w/o infusion for management of acute intermediate-risk PE. #CardioTwitter #ACCFIT

sciencedirect.com/science/articl…
Vladimir Lakhter (@vladlakhter) 's Twitter Profile Photo

7/ RESCUE-II results provide an exciting signal that bolus-only r-tPA without post-procedural infusion is feasible and may be an effective treatment option for management of pt’s with intermediate-risk PE

Michael Megaly (@michaelmegalymd) 's Twitter Profile Photo

A lot of work has been done on the impact of #CTO #PCI on LVEF, which I believe is largely due to reversing ischemia and hybernation in true ischemic CM patients. This is most pronounced in LAD CTO PCI patients. Our new paper American Journal of Cardiology studies the impact of Non-LAD CTO PCI on

A lot of work has been done on the impact of #CTO #PCI on LVEF, which I believe is largely due to reversing ischemia and hybernation in true ischemic CM patients. This is most pronounced in LAD CTO PCI patients. 

Our new paper <a href="/AmJCardio/">American Journal of Cardiology</a> studies the impact of Non-LAD CTO PCI on